Transcription of See full prescribing information for complete …
{{id}} {{{paragraph}}}
HIGHLIGHTS OF prescribing information These highlights do not include all the information needed to use BLINCYTO safely and effectively. See full prescribing information for BLINCYTO. BLINCYTO (blinatumomab) for injection, for intravenous use Initial Approval: 2014 WARNING: CYTOKINE RELEASE SYNDROME and NEUROLOGICAL TOXICITIES See full prescribing information for complete boxed warning. Cytokine Release Syndrome (CRS), which may be life-threatening or fatal, occurred in patients receiving BLINCYTO. Interrupt or discontinue BLINCYTO as recommended.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BLINCYTO® safely and effectively. See full prescribing information for BLINCYTO.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}